Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
558.15
Change Change %
-1.55 -0.28%

Updated:06 Dec, 2019, 11:44 AM IST

BSE
558.00
Change Change %
-1.40 -0.25%

Updated:06 Dec, 2019, 11:57 AM IST

Alembic Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'19
(₹ Cr.)
MAR'18
(₹ Cr.)
Change %
Net Profit Before Taxes 764.63 535.22 42.86%
Adjustments for Expenses & Provisions 94.49 81.90 15.37%
Adjustments for Liabilities & Assets 107.37 -188.46 156.97%
Cash Flow from operating activities 808.80 304.55 165.57%
Cash Flow from investing activities -753.59 -793.58 5.04%
Cash Flow from financing activities 79.67 497.80 -84.00%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents 134.88 8.77 1437.97%
Opening Cash & Cash Equivalents 9.44 0.68 1288.24%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations -0.07 0.00 100.00%
Closing Cash & Cash Equivalent 144.25 9.45 1426.46%
Top